I

n an age with few vaccine makers and still fewer vaccines for many dangerous diseases, a new report card finds that the most important manufacturers are, by and large, doing a mixed job of making their products available to the neediest countries.

Of the six vaccine makers that were evaluated, only GlaxoSmithKline was notable for its efforts in the three categories that were measured: developing new products, making its vaccines affordable, and ensuring that production meets demand, according to the latest Access to Vaccines Index.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.